ARCHIVES

NCI Largely Unaffected By NIH Translational Research Center

This article is from The Cancer Letter archive.

Vol. 37 No. 06 | February 11, 2011

Download PDF Visit The Full Archive

Related Articles

Professional Societies: Three Groups To File brief In Fisher’s Appeal

October 11, 1996

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

October 29, 2004

NCI Still Trying To Broaden Group B Drug Distribution

May 5, 1978

NCI Receives 165 SBIR Grant Applications; Combines With Solid Contracts, No More Fiascos Are Expected

June 14, 1985

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

DCBD To Increase Emphasis On Workshops, Cut Program Initiatives

November 8, 1985